Company News: Merck (MRK) quarterly results beat analysts’ forecasts

Market news

28 April 2020

Company News: Merck (MRK) quarterly results beat analysts’ forecasts

Merck (MRK) reported Q1 FY 2020 earnings of $1.50 per share (versus $1.22 per share in Q1 FY 2019), beating analysts' consensus estimate of $1.34 per share.

The company's quarterly revenues amounted to $12.057 bln (+11.5% y/y), beating analysts' consensus estimate of $11.458 bln.

The company also lowered guidance for FY 2020, projecting EPS of $5.17-5.37 (down from $5.62-5.77 previously) versus analysts' consensus estimate of $5.54 and revenues of $46.1-48.1 bln (down from $48.8-50.3 bln previously) versus analysts' consensus estimate of $48.65 bln.

MRK fell to $82.51 (-1.75%) in pre-market trading.

Company News: Pfizer (PFE) quarterly results beat analysts’ expectations

ECB: A move on rates remains highly unlikely – UOB

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.